Pfizer partners with Beam to develop rare disease therapies

By NS Healthcare Staff Writer

11 Jan 22

Under the four-year research collaboration, the companies will focus on in vivo base editing programmes for three targets…

PharmaceuticalsBiotechnology Equipment and Materials

Sanofi to buy Origimm Biotechnology for vaccine candidate to treat acne

By NS Healthcare Staff Writer

02 Dec 21

Origimm is engaged in discovering virulent skin microbiome components and antigens from bacteria that cause skin disease, including…

PharmaceuticalsBiotechnology Equipment and Materials

Serum Life Sciences to invest £50m in Oxford Biomedica

By NS Healthcare Staff Writer

23 Sep 21

In exchange for the investment, Serum Life Sciences will subscribe for 3,382,950 new ordinary shares of Oxford Biomedica

PharmaceuticalsBiotechnology Equipment and Materials

Diagnostics for the detection of biofilms continue to develop

ByNatalie Healey

23 Aug 21

Detecting biofilms is a real problem for wound care, but there are new diagnostic tools available that practitioners…

Biotechnology Equipment and Materials

Sanofi to acquire mRNA therapeutics firm Translate Bio for $3.2bn

By NS Healthcare Staff Writer

04 Aug 21

The acquisition of Translate Bio will help French drugmaker Sanofi to further advance the development of transformative medicines…

PharmaceuticalsBiotechnology Equipment and Materials

Autolus, Moderna sign licencing agreement for mRNA therapeutics

By NS Healthcare Staff Writer

03 Aug 21

Moderna will make an upfront payment for each target it licensed from Autolus, in addition to milestone payments…

PharmaceuticalsBiotechnology Equipment and Materials

PerkinElmer to acquire reagent maker BioLegend for $5.5bn

By NS Healthcare Staff Writer

27 Jul 21

The acquisition of BioLegend, the largest transaction in PerkinElmer’s history, will expand its existing life science franchise into…

PharmaceuticalsBiotechnology Equipment and Materials

Lilly acquires Protomer Technologies in $1bn deal

By NS Healthcare Staff Writer

15 Jul 21

In a previous equity investment round, Lilly acquired a 14% stake in California-based Promoter

PharmaceuticalsBiotechnology Equipment and Materials

Danaher to acquire biologics manufacturer Aldevron for $9.6bn

By NS Healthcare Staff Writer

18 Jun 21

Upon closing of the transaction, Aldevron will operate as an individual company and a brand operating within Danaher's…

PharmaceuticalsBiotechnology Equipment and Materials

Fujifilm to invest $40m to build viral vector manufacturing facility in US

By NS Healthcare Staff Writer

05 Jan 21

The new facility, to be located in Watertown, Massachusetts, will manufacture viral vectors and advanced therapies

PharmaceuticalsBiotechnology Equipment and Materials